Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,21,0.98 [0.81-1.18],0.827735342108694
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,21,1.02 [0.95-1.09],0.667781987957569
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,21,1.03 [0.96-1.09],0.411591354820989
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,21,1.06 [0.93-1.21],0.35704744796192
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,21,1.09 [1.03-1.16],0.0048838036493346
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,21,2.26 [0.91-5.59],0.0791352931699394
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,21,1.06 [0.95-1.18],0.288833839626026
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,21,1.02 [0.40-2.61],0.974250532961884
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,21,1.01 [0.88-1.16],0.932045203831192
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,21,1.06 [0.70-1.62],0.77951091818181
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,21,0.94 [0.75-1.17],0.57535568942501
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,21,1.29 [0.91-1.82],0.151600592399689
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,21,0.93 [0.76-1.14],0.491157313405425
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,21,1.55 [0.96-2.50],0.0700520329154726
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,21,0.96 [0.84-1.10],0.571498538052139
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,21,1.04 [0.93-1.15],0.506218180484576
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,21,1.53 [0.77-3.04],0.223681295707126
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,21,1.03 [0.86-1.25],0.743121120256294
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,21,1.02 [0.78-1.33],0.900763570011471
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,21,0.92 [0.73-1.15],0.453971731625319
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,21,0.95 [0.75-1.21],0.684554483461886
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,21,1.17 [0.69-2.01],0.560588070556623
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,21,1.20 [0.91-1.59],0.187694333993055
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,21,0.99 [0.77-1.27],0.929914268293749
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,21,0.84 [0.66-1.07],0.160552566536637
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,21,0.96 [0.84-1.10],0.547531519491367
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,21,1.00 [0.89-1.13],0.955444334874279
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,21,1.00 [0.80-1.26],0.976790077414693
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,21,0.82 [0.60-1.13],0.225321472554691
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,21,0.94 [0.78-1.13],0.505593464838481
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,21,1.09 [0.92-1.28],0.332200787751844
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,21,1.20 [0.94-1.54],0.144496946522269
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,21,0.97 [0.82-1.14],0.689095376762284
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,21,1.89 [0.77-4.64],0.163686785366352
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,21,0.97 [0.92-1.03],0.362712956348046
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,21,0.93 [0.74-1.17],0.55869705204697
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,21,1.08 [0.87-1.34],0.491954978409485
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,21,1.03 [0.97-1.09],0.315067643261195
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,21,1.04 [0.88-1.24],0.636603472845307
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,21,1.02 [0.84-1.23],0.852761626420871
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,21,1.06 [0.96-1.17],0.232090551989393
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,21,0.89 [0.69-1.15],0.386954012139472
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,21,0.97 [0.88-1.08],0.618649307464893
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,21,0.91 [0.70-1.19],0.512133314479704
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,21,0.97 [0.90-1.05],0.465732788286583
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,21,0.99 [0.83-1.19],0.929488634326777
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,21,1.16 [0.54-2.49],0.712017485954493
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,21,1.06 [0.74-1.53],0.753322681092963
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,21,0.98 [0.89-1.08],0.695845183156406
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,21,1.07 [0.79-1.44],0.675033613958703
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,21,1.37 [0.95-1.98],0.0924330363256457
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,21,0.84 [0.66-1.08],0.171651772798802
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,21,1.20 [1.00-1.45],0.0558342265846112
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,21,1.01 [0.89-1.16],0.849424302958623
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,21,0.89 [0.62-1.28],0.531990275739086
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,21,1.08 [0.74-1.57],0.679342781835519
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,21,1.08 [0.95-1.22],0.250734199702443
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,21,0.97 [0.82-1.15],0.747199677777065
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,21,0.83 [0.68-1.02],0.0741576421841878
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,21,1.19 [0.99-1.42],0.0588262884082642
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,21,0.96 [0.85-1.10],0.578873784022996
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,21,1.02 [0.96-1.08],0.568913924176353
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,21,0.94 [0.87-1.02],0.154078854793195
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,21,1.06 [0.95-1.18],0.262172654677333
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,21,1.13 [0.93-1.36],0.224142835709102
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,21,1.12 [0.88-1.43],0.363794544931505
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,21,1.18 [0.69-2.01],0.549102095620588
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,21,1.12 [0.90-1.41],0.304580959008676
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,21,1.04 [0.97-1.11],0.240383013774483
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,21,1.05 [0.86-1.28],0.661862704627892
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,21,0.95 [0.86-1.06],0.369091667620185
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,21,1.25 [0.95-1.65],0.118117380368304
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,21,1.11 [0.73-1.69],0.631656650045404
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,21,1.07 [0.93-1.24],0.335035960411013
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,21,1.02 [0.91-1.14],0.773632434129546
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,21,1.00 [0.86-1.17],0.954283299761041
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,21,1.01 [0.86-1.17],0.933811518639831
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,21,1.02 [0.91-1.13],0.775606309763602
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,21,1.00 [0.87-1.14],0.958084928546708
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,21,1.35 [1.02-1.78],0.0331296356541389
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,21,1.01 [0.75-1.36],0.945003290788874
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,21,0.80 [0.60-1.06],0.11383911413764
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,21,1.15 [0.99-1.33],0.0647815825265388
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,21,1.12 [0.82-1.51],0.477117471280645
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,21,1.02 [0.94-1.11],0.627134061146522
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,21,0.95 [0.88-1.03],0.213532351341182
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,21,0.98 [0.81-1.18],0.803798283964078
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,21,1.01 [0.87-1.18],0.892090247696279
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,21,0.96 [0.88-1.06],0.446818533583243
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,21,0.92 [0.80-1.06],0.268455263712602
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,21,1.02 [0.95-1.09],0.588026032133867
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [SjÂšgren],Inverse variance weighted,21,1.06 [0.84-1.34],0.610145185397618
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,21,1.03 [0.97-1.09],0.322341713216578
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,21,1.28 [0.94-1.74],0.112520922325347
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,21,1.03 [0.97-1.11],0.330281564154167
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,21,0.96 [0.82-1.12],0.631838630264546
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,21,0.95 [0.63-1.44],0.819985783928722
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,21,1.02 [0.90-1.16],0.769813438208138
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,21,1.16 [0.77-1.74],0.490974133681555
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,21,0.96 [0.75-1.23],0.745196341938107
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,21,1.08 [0.88-1.33],0.447790387795279
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,21,1.14 [0.92-1.42],0.223179822064753
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,21,1.08 [0.89-1.31],0.42076951610801
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,21,1.08 [0.72-1.61],0.710325905384046
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,21,0.66 [0.28-1.57],0.345314286499001
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,21,0.97 [0.91-1.04],0.433780679463198
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,21,1.03 [0.82-1.30],0.797661721550546
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,21,0.87 [0.67-1.13],0.286611853930643
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,21,1.05 [0.98-1.13],0.166563024605651
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,21,1.05 [0.99-1.12],0.119120013001144
TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,21,0.91 [0.67-1.22],0.508854985392432
